Cinnamon, the popular spice in Indian cuisine, is known to possess several health benefits and this has been validated by the latest study by ICMR-National Institute of Nutrition (NIN) on Friday.
The study demonstrated that cinnamon and its active components—cinnamaldehyde and procyanidin B2—when administered orally to rats had an inhibitory effect on early-stage prostate cancer. The study aimed to assess the chemopreventive efficacy of cinnamon (CN) and its bioactive compounds (cinnamaldehyde or procyanidin B2) in vivo in male rats.
As part of this study, adult rats were given cinnamon or its bioactive compounds through the diet for 16 weeks before induction of cancer. It was observed that feeding cinnamon or its active compounds resulted in 60-70% of rats showing normal prostate histologically.
